Aikido Pharma Inc AIKI:NASDAQ

Last Price$0.47Cboe Real-Time Last Sale as of 3:10PM ET 1/27/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.04(7.67%)
Bid (Size)$0.47 (100)
Ask (Size)$0.47 (300)
Day Low / High$0.47 - 0.51
Volume654.9 K

AIkido Pharma, University of Maryland Identify Four Lead Compounds Blocking Viral Replication

11:13AM ET 7/16/2021 MT Newswires
AIkido Pharma (AIKI) and its partner, the University of Maryland, have identified four lead compounds that could inhibit the replication of multiple viruses, including influenza, coronavirus, and ebola, they said Friday.

In April last year, the company and the University of Maryland entered into a license agreement covering specific antiviral compounds discovered by the university.

"Ultimately the goal is to have compounds that demonstrate strong antiviral activity against Influenza virus, SARS-CoV-2, and Ebolavirus," Alkido Pharma Chief Executive Anthony Hayes said.

The next step is to measure how well the compounds are bioavailable in the lungs when given either as an injection or as an oral dosing, according to a statement.

Price: 0.85, Change: -0.01, Percent Change: -0.90